Mizuho Lowers Waystar Holding Corp. (WAY) Price Target to $42 Amid Competitive Healthcare Tech Risks

Laiba Immad

Wed, February 18, 2026 at 3:22 PM GMT+9 2 min read

In this article:

WAY

+8.48%

Waystar Holding Corp. (NASDAQ:WAY) is among the 15 Innovative Healthcare Stocks to Buy According to Analysts.

Mizuho Lowers Waystar Holding Corp. (WAY) Price Target to $42 Amid Competitive Healthcare Tech Risks

The fourth stock on this list is Waystar Holding Corp. (NASDAQ:WAY).

TheFly reported on February 4 that Mizuho lowered its price target on WAY to $42 from $50 while maintaining an Outperform rating. The reduction reflects the firm’s reassessment of competitive risks within the healthcare technology sector.

Additionally, earlier on February 2, Leerink initiated coverage of Waystar Holding Corp. (NASDAQ:WAY) with an Outperform rating and a $43 price target. The firm thinks that WAY’s broad market reach, which opens doors for further client penetration and growth, positions the company to maintain growth. Leerink added that the company’s end-to-end products are improved and its artificial intelligence capabilities are strengthened by the recent acquisition of Iodine. A more complete, one-stop solution for health systems is supported by these additional capabilities, which may provide incremental benefits as the platform develops.

Waystar Holding Corp. (NASDAQ:WAY) also announced on February 6 that Chief Business Officer Eric Sinclair III will resign effective March 2, 2026. Sinclair’s departure is not related to any disagreements with the company, and he will receive his 2025 annual bonus but no additional severance. On the innovation front, WAY has incorporated agentic intelligence into its healthcare payment platform and upgraded its AltitudeAI system. The enhancement has already prevented $15.5 billion in claim denials in under a year, which shows the company’s ongoing efforts to strengthen its operational capabilities despite a challenging market environment.

Waystar Holding Corp. (NASDAQ:WAY) is a U.S. healthcare technology company that simplifies and modernizes healthcare payments with a cloud‑native, AI‑powered revenue cycle management platform. Its innovative use of automation, machine learning, and analytics improves claim accuracy, efficiency, and patient payment experiences for providers nationwide.

While we acknowledge the potential of WAY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 10 Most Profitable Undervalued Stocks to Buy and 11 Best Mining Stocks to Buy According to Wall Street.

Disclosure: None.

Terms and Privacy Policy

Privacy Dashboard

More Info